pharmaphorum Daily newsletter - 15th Nov. 2024
pharmaphorum
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
This Friday, President-Elect Donald Trump’s pick of Robert F Kennedy Jr as US Health and Human Services Secretary astounded critics. Politicians and health scientists reacted.
Meanwhile, MSD has joined the PD-1/VEGF push in cancer with a licensing deal with Chinese biotech LaNova Medicines , and UK-based life science investor Syncona Limited has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown development projects.
Elsewhere, 荷商葛蘭素史克藥廠 hails survival data with revived myeloma drug Blenrep.
In our longer reads today, peruse tips to strengthen clinical trials by improving the patient experience, and don’t forget to catch up with this week’s previous features. As we step into the weekend, you might also want to tune in to any podcasts, videos, or webinars on demand not yet enjoyed, too…
All this and more on pharmaphorum.com
News
Last night, news broke that President-Elect Donald Trump had nominated Robert F Kennedy Jr (aka RFK Jr) as US Health Secretary. This morning, the public and health scientists react to the controversial decision.
There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn't left behind.
UK-based life science investor Syncona has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown development projects.
GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical significance.
Views & Analysis
From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs. Conversely, systemically gathering their feedback and incorporating it into the design can increase their interest and trust. Consequently, sponsor companies that take a patient-centred approach to study designs may find that it goes a long way toward raising general trust in the pharmaceutical industry.
While artificial intelligence has proven to be a valuable tool for automating repetitive, laborious tasks, it has also become a valuable resource for simplifying complex tasks. There is no better example of this approach to AI than how it can be utilised in the operating room, where surgeons and pathologists use it to help with processes like disease diagnosis to make operations safer and more successful.
Prepare for 2025 with pharmaphorum’s Life Sciences Industry Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends.
The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential drug ingredients.
领英推荐
In response to the rise of AMR, world leaders recently convened at the United Nations General Assembly to forge a landmark commitment, setting ambitious targets and funding initiatives to curb the spread of drug-resistant infection.
Podcasts & Videos
In today’s podcast, web editor Nicole Raleigh speaks with Dr Samuel Ewing, global head of pharma partnerships at Doccla, about the next generation of digital tools such as wearable medical devices, as well as remote patient monitoring and digital healthcare generally.
In another pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Neal Kassell, chair and founder of the Focused Ultrasound Foundation and previously a neurosurgeon, who created the Foundation in 2006 to improve the lives of millions of people with serious medical disorders by accelerating the development and adoption of focused ultrasound.
In this pharmaphorum podcast, web editor Nicole Raleigh speaks with Matt Hollingsworth, co-founder and CEO of Carta Healthcare, a company seeking to support the healthcare data registry market by transforming a previously manual clinical data abstraction process.
In a new podcast, web editor Nicole Raleigh speaks with Dr Evan Floden, CEO and co-founder of Seqera, a data orchestration and genomics analysis company, about barriers of entry to genomic surveillance in public health labs and how these can be lowered to support future bioinformaticians, aiding acceleration and quality and accuracy in R&D.
At LSX in Boston, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some recent news.
Webinars & White Papers
Join us NEXT WEEK, on Tuesday 19th November at 11am EST / 5pm CET / 4pm GMT, for a webinar sponsored by PurpleLab and learn how to gain a competitive edge by understanding physician prescribing behaviour in target markets.
In a webinar sponsored by Syneos Health - with Atlas Clinical Research’s Chief Executive Officer Mark Scullion, and Batisha Anson, Global Head of Patient Diversity and Health Equity at Syneos Health - learn more about the site experience for clinical research sites. Now available on demand.
Join us on Wednesday 4th December @ 2pm GMT - 3pm CET - 9am EST for an exclusive webinar, sponsored by Trueblue , to learn how life sciences organisations are leveraging the power of AI-driven strategic insights to revolutionise decision-making, enhance customer engagement, and gain a competitive edge.
Discover how to balance personalised engagement with regulatory compliance across global pharma markets in a webinar presented by EVERSANA INTOUCH . Available on demand now.
In a Socially Determined sponsored webinar, discover how industry leaders are harnessing non-clinical data to enhance recruitment, retention, and broader evidence generation. Now available on demand.
Homecare pharmacist ?? men's & mental health advocate ?? mindbodyspirit practitioner ??
3 个月Talk about action-packed content! ?? ?? ??